SNWV

#4347
SANUWAVE Health, Inc. - Common Stock
4.8 2 USD
+0.03%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
4.67
4.84
Intervallo Annuale
4.50
25.62
Variazione giornaliera
+2.99%
Variazione Mensile
-21.88%
Variazione di 6 mesi
-79.92%
Variazione Annuale
-80.06%
Chiusura Precedente
4.6 8
Open
4.6 7
Minimo
4.6 7
Massimo
4.8 4
Volume
19
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
SANUWAVE Health, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
SANUWAVE Health, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K

SANUWAVE Health, Inc. current report, Q1 FY2024

Full document

Business Context and Reporting Period

Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 22, 2024
Reporting Period: Fourth quarter and fiscal year ended December 31, 2023.

The Company issued a press release on March 22, 2024, announcing financial results for the specified period. A business update conference call was scheduled for the same date.

Key Financial Metrics

The provided Form 8-K text serves as a notification of the results announcement and does not contain specific numerical data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.

Material Changes

The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors are directed to the attached press release (Exhibit 99.1) and the Company's investor website for detailed operational and financial comparisons.

Guidance, Outlook, and Risks

Management Commentary: The Company indicated that a business update would be provided via a conference call on March 22, 2024, at 8:30 am EST.
Forward-Looking Information: The filing explicitly states that the information in Item 2.02 and attached exhibits shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference in any filing under the Securities Act of 1933, except as expressly set forth by specific reference.
Risks and Contingencies: No specific risks or contingencies are detailed within the text of this Form 8-K.

Investor Verification Checklist

  • Review the attached Press Release (Exhibit 99.1) for specific Q4 and full-year 2023 financial figures.
  • Access the Company's investor website (www.sanuwave.com/investors) for the conference call materials and transcript.
  • Verify the Company's status as an emerging growth company (indicated as unchecked in the filing).
  • Confirm that the financial data in the press release is not automatically incorporated by reference into other SEC filings without specific citation.